Around 5% of healthy adults exposed to cannabidiol show elevated liver enzyme levels exceeding the normal threshold alongside ...

Cannabidiol within the range consumers are taking with unregulated products linked to increase in liver enzymes.

Adolescent vaping of delta-9-tetrahydrocannabinol, cannabidiol, and synthetic cannabinoids increased significantly from 2021 to 2023.

(Alliance News) - Ananda Pharma PLC on Tuesday said the first subject has been dosed in the phase 1 pharmacokinetic study for its lead cannabidiol drug candidate, MRX1. Ananda is a London-based ...

A new study published in the Journal of Cannabis Research and indexed by the U.S. National Library of Medicine has found that ...

While Patients Suffer, DEA Manipulates Due Process to Cover Its Cannabis Crimes. The DEA blocking federally compliant ...

FDA researchers report that the upper end of reported consumer use (~400mg of daily CBD intake) of cannabidiol (CBD) may ...

Market OverviewThe global Epilepsy Drugs Market is valued at USD 10.63 billion in 2024 and is projected to reach a value ...

An FDA-funded clinical trial found even modest CBD use triggered elevated liver enzymes in some healthy adults, raising ...